OQROGet OQRO Pro
Politician trade (House)

Merck (MRK)Rep. Rob Bresnahan (PA08) disclosed a sale $15K–$50K

Rep. Rob Bresnahan (PA08) disclosed a sale of Merck in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
30 days
Disclosure lag
Traded
Feb 25, 2025
Disclosed
Mar 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 15, 2025Congress · 1 personMembers of Congress: 3 sales
  2. Jan 16, 2025Congress · 1 personMembers of Congress: 2 sales
  3. Jan 17, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  4. Jan 24, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  5. Jan 27, 2025CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  6. Jan 28, 2025FDAFDA drug approval: Keytruda
  7. Feb 5, 2025InsiderDirector purchased ~$1.33M of MRK shares in the open market
  8. Feb 6, 2025Insider · 2 peopleInsiders: 1 purchase (~$250K), 1 sale (~$210K)
  9. Feb 12, 2025Court · District Court, D. New JerseySecurities lawsuit filed: IN RE MERCK & CO., INC. SECURITIES LITIGATION
  10. Feb 13, 2025InsiderOfficer sold ~$512K of MRK shares in the open market
  11. Feb 19, 2025InsiderOfficer sold ~$715K of MRK shares in the open market
  12. Feb 24, 2025CongressDisclosed purchase of MRK — reported range $15,001 - $50,000
  13. Feb 25, 2025 · this disclosureCongressDisclosed sale of MRK — reported range $15,001 - $50,000

What came next

  1. Feb 26, 2025CongressDisclosed purchase of MRK — reported range $15,001 - $50,000
  2. Mar 3, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  3. Mar 19, 2025FDAFDA drug approval: Keytruda
  4. Mar 20, 2025CongressDisclosed partial sale of MRK — reported range $1,001 - $15,000
  5. Mar 31, 2025CongressDisclosed partial sale of MRK — reported range $15,001 - $50,000
  6. Apr 8, 2025CongressDisclosed purchase of MRK — reported range $15,001 - $50,000
  7. Apr 9, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  8. Apr 15, 2025FDAFDA drug approval: Welireg
  9. Apr 15, 2025FDAFDA drug approval: Welireg
  10. Apr 17, 2025CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  11. Apr 21, 2025FDAFDA drug approval: Keytruda
  12. Apr 21, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  13. Apr 25, 2025InsiderOfficer sold ~$353K of MRK shares in the open market
  14. Apr 29, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  15. May 5, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  16. May 14, 2025FDAFDA drug approval: Welireg
  17. May 15, 2025CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  18. May 22, 2025FDAFDA drug approval: Keytruda
  19. May 30, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  20. Jun 3, 2025FDAFDA drug approval: Keytruda
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Merck

For Merck, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 123 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.

Other recent filings by Rep. Rob Bresnahan (PA08)

The full history of Rep. Rob Bresnahan (PA08) is on the profile page.

How this filing works

Other disclosures at Merck

Everything OQRO holds on this company is on its MRK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data